Skip to content

NRXP

NRX Pharmaceuticals, Inc.

NASDAQ · Healthcare · Biotechnology · US

$3.32
−2.06%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 13, 2026
EPS estimate
-$0.26
Revenue estimate
$1.3M

Latest reported

Last report date
Aug 17, 2026
EPS actual
-$0.44
EPS estimate
-$0.11
Revenue actual
$1.1M
Revenue estimate
$1.3M

Track record

Trailing twelve quarters

EPS beats (12Q)
7
EPS misses (12Q)
5
EPS in line (12Q)
0
Avg surprise (4Q)
+173.5%
Revenue beats (12Q)
0

Analyst ratings

Sell-side consensus

Consensus
Buy
Price target
$28
PT range
$10 – $45
Analysts
2
2 Buy0 Hold0 Sell
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 17, 2026-$0.11-$0.44Miss -312.49%$1.1M
May 18, 2026-$0.05-$0.04Beat 20.00%$1.1M
Mar 24, 2026-$0.02$0.19Beat 1050.00%$998.0K
Nov 14, 2025-$0.11-$0.18Miss -63.64%$242.0K
May 15, 2025-$0.30-$0.34Miss -13.33%$2.3M
Mar 14, 2025-$0.20-$0.30Miss -50.00%
Nov 14, 2024-$0.81-$0.15Beat 81.48%
Aug 14, 2024-$0.81-$0.75Beat 7.41%
May 14, 2024-$0.55-$0.74Miss -34.55%
Nov 13, 2023-$1.10-$0.70Beat 36.36%
Aug 14, 2023-$1.40-$1.20Beat 14.29%
May 16, 2023-$1.50-$1.30Beat 13.33%

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 13, 2026